Inventor profile of:

James J. Doherty

City:

Bedford, Massachusetts

Country:

United States

Published Applications:

20

Last publication date:

2025-12-25

Top Assignees for applications by James J. Doherty

The entities that hold a legal rights for patent applications filed by inventor Doherty James J.:

Recent patent applications by Doherty James J.

James J. Doherty from Bedford, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-12-25
US20250387414A1
Human necessities

19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF

#2 | 2025-11-06
US20250339447A1
Human necessities

19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF

#3 | 2025-10-02
US20250304615A1
Chemistry; metallurgy

CRYSTALLINE 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID

#4 | 2025-08-28
US20250268916A1
Human necessities

METHOD OF TREATING CNS DISORDERS WITH NEUROSTEROIDS AND GABAERGIC COMPOUNDS

#5 | 2024-10-24
US20240353415A1
Physics

METHOD OF SCREENING COMPOUNDS FOR TREATING CNS DISORDERS

#6 | 2023-12-14
US20230399357A1
Chemistry; metallurgy

CRYSTALLINE 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID

#7 | 2023-07-13
US20230218638A1
Human necessities

NEUROACTIVE COMPOUNDS AND METHODS OF USE THEREOF

#8 | 2023-06-29
US20230201224A1
Human necessities

19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF

#9 | 2023-04-13
US20230116196A1
Human necessities

METHOD OF TREATING CNS DISORDERS WITH NEUROSTEROIDS AND GABAERGIC COMPOUNDS

#10 | 2022-10-13
US20220323462A1
Human necessities

19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF

#11 | 2022-06-02
US20220169674A1
Chemistry; metallurgy

Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid

#12 | 2022-04-14
US20220110949A1
Human necessities

A 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF

#13 | 2021-12-02
US20210369734A1
Human necessities

COMPOUNDS AND METHODS OF THEIR USE

#14 | 2021-11-04
US20210338692A1
Human necessities

A 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF

#15 | 2021-07-29
US20210228596A1
Human necessities

METHOD OF TREATING CNS DISORDERS WITH NEUROSTEROIDS AND GABAERGIC COMPOUNDS

#16 | 2020-10-29
US20200341000A1
Physics

METHOD OF SCREENING COMPOUNDS FOR TREATING CNS DISORDERS

#17 | 2020-10-01
US20200306262A1
Human necessities

COMPOUNDS AND METHODS OF THEIR USE

#18 | 2020-04-16
US20200113917A1
Human necessities

19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF

#19 | 2019-06-13
US20190177359A1
Chemistry; metallurgy

Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid

#20 | 2017-10-26
US20170304321A1
Human necessities

NEUROACTIVE COMPOUNDS AND METHODS OF USE THEREOF

InventorID:

2018362 ⎘